The United States Trotting Association said June 16 it will fund a project designed to develop regulatory controls for the use of cobalt in racehorses.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- Jockey Bain, 62, Wins Again at Gulfstream
- Shared Belief Sprints to Game Malibu Triumph
- Sam's Sister Stuns Taris in Quick La Brea
- California Chrome is Vox Populi Award Winner
- Prado 'Day to Day' After Gulfstream Spill
- Alert Bay Wins Mathis Brothers Mile Thriller
- Nine-Month Suspension Recommended for Veitch
- Leave the Light On for Storm Cat
- Six Grade I Races Set for Belmont Stakes Day
- WV Racing Struggles With Plan for Stability